Business Description
AnaptysBio Inc
NAICS : 325412
SIC : 2834
ISIN : US0327241065
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 20.7 | |||||
Equity-to-Asset | 0.02 | |||||
Debt-to-Equity | 1.72 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.9 | |||||
Beneish M-Score | -1.55 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.6 | |||||
3-Year EBITDA Growth Rate | -99.4 | |||||
3-Year EPS without NRI Growth Rate | -99.6 | |||||
3-Year FCF Growth Rate | -103.1 | |||||
3-Year Book Growth Rate | -38.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | -5.32 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.42 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.5 | |||||
9-Day RSI | 54.39 | |||||
14-Day RSI | 52.7 | |||||
6-1 Month Momentum % | 76.8 | |||||
12-1 Month Momentum % | 95.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.09 | |||||
Quick Ratio | 9.09 | |||||
Cash Ratio | 8.68 | |||||
Days Sales Outstanding | 70.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -0.05 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -508.81 | |||||
Net Margin % | -558.25 | |||||
FCF Margin % | -426.86 | |||||
ROE % | -205.16 | |||||
ROA % | -37.14 | |||||
ROIC % | -248.47 | |||||
3-Year ROIIC % | -436.54 | |||||
ROC (Joel Greenblatt) % | -788.03 | |||||
ROCE % | -34.17 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 31.02 | |||||
PB Ratio | 97.64 | |||||
Price-to-Tangible-Book | 96.97 | |||||
EV-to-EBIT | -4.99 | |||||
EV-to-Forward-EBIT | -3.83 | |||||
EV-to-EBITDA | -5.08 | |||||
EV-to-Forward-EBITDA | -5.15 | |||||
EV-to-Revenue | 23.52 | |||||
EV-to-Forward-Revenue | 14.24 | |||||
EV-to-FCF | -5.6 | |||||
Earnings Yield (Greenblatt) % | -20.02 | |||||
FCF Yield % | -12.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AnaptysBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 28.164 | ||
EPS (TTM) (€) | -5.877 | ||
Beta | 0.66 | ||
Volatility % | 70.64 | ||
14-Day RSI | 52.7 | ||
14-Day ATR (€) | 1.262525 | ||
20-Day SMA (€) | 30.77 | ||
12-1 Month Momentum % | 95.12 | ||
52-Week Range (€) | 12.3 - 36.4 | ||
Shares Outstanding (Mil) | 30.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AnaptysBio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AnaptysBio Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AnaptysBio Inc Frequently Asked Questions
What is AnaptysBio Inc(FRA:AN6)'s stock price today?
When is next earnings date of AnaptysBio Inc(FRA:AN6)?
Does AnaptysBio Inc(FRA:AN6) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |